Added to YB: 2026-09-24
Pitch date: 2026-09-18
TEM [bullish]
Tempus AI, Inc.
-3.15%
current return
Author Info
Stock Pursuit researches domestic deep value equities below net cash, net current asset value or net tangible assets. Sign up for the newsletter.
Company Info
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician’s desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests.
Market Cap
$14.0B
Pitch Price
$79.08
Price Target
N/A
Dividend
N/A
EV/EBITDA
-81.71
P/E
-54.29
EV/Sales
10.25
Sector
Life Sciences Tools and Services
Category
growth
The Future Of Medicine: Tempus AI
TEM (more research needed): Tempus AI combines scaled diagnostics with a continuously replenished, multimodal clinical dataset that pharmaceutical companies license for drug development and AI workflows. Sales are growing over 25% annually, trailing-twelve-month gross margin has risen from 32% in 2021 to 64%, and recent Q2 data and application licenses totaled $200M. The platform opportunity is compelling, but the stated $14B valuation and path to meaningful EBITDA and free cash flow still require deeper financial analysis.
Read full article (7 min)